Some candidate cancer drugs fail in clinical trials while others succeed in unintended ways. According to a new paper published on 11 September in Science Translational Medicine, many candidate drugs
Some candidate cancer drugs fail in clinical trials while others succeed in unintended ways. According to a new paper published on 11 September in Science Translational Medicine, many candidate drugs